Commercially-prepared allograft material has biological activity in vitro

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cell Biology

Background:

• Demineralized bone matrix (DBM) is used for bone regeneration, attributed to bone morphogenetic proteins (BMPs).
• Commercial DBM allografts are widely used in clinical settings for bone reconstruction.
• The biological activity of proteins within commercial DBM requires further in vitro investigation.

Purpose of the Study:

• To assess the in vitro biological activity of protein extracts from commercial DBM.
• To compare the activity of commercial DBM extracts with those from fresh human bone.
• To evaluate the effects of DBM proteins on gingival fibroblast proliferation, attachment, and migration.

Main Methods:

• Protein extraction using guanidine and guanidine/EDTA to isolate bone matrix proteins.
• Slot blot analysis to identify specific proteins, including collagen, fibronectin, BSP, and BMPs (BMP-2, 4, 7).
• In vitro assays to measure fibroblast proliferation, attachment, and migration using prepared extracts.

Main Results:

• Commercial DBM contained collagen, fibronectin, BSP, and BMPs, but fresh bone extracts had higher BMP concentrations.
• Commercial extracts significantly promoted cell attachment but showed limited and reduced cell proliferation compared to fresh bone extracts.
• No extracts demonstrated a significant effect on cell migration.

Conclusions:

• Commercially prepared DBM retains proteins capable of influencing cellular behavior.
• Tissue processing for commercial DBM appears to result in a loss of some in vitro biological activity.
• Freshly obtained bone may offer superior biological potential for regenerative applications compared to processed allografts.